20 results
SC TO-T
EX-99
PNT
POINT Biopharma Global Inc.
13 Oct 23
Third party tender offer statement
6:52am
;
compliance with laws, including anti-corruption and anti-bribery laws;
regulatory matters;
environmental matters;
intellectual property and computer
SC14D9C
EX-2.1
PNT
POINT Biopharma Global Inc.
3 Oct 23
Written communication relating to third party tender offer
7:37am
of the Foreign Corrupt Practices Act of 1977, as amended, or any other applicable anti-bribery, anti-corruption, anti-money laundering, record keeping … and internal control Laws, including any such Laws that prohibit private commercial bribery or (iv) made, offered or authorized any other bribe, unlawful rebate
8-K
EX-2.1
PNT
POINT Biopharma Global Inc.
3 Oct 23
Tender and Support Agreement
7:35am
of the Foreign Corrupt Practices Act of 1977, as amended, or any other applicable anti-bribery, anti-corruption, anti-money laundering, record keeping … and internal control Laws, including any such Laws that prohibit private commercial bribery or (iv) made, offered or authorized any other bribe, unlawful rebate
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
with applicable healthcare laws may involve substantial costs. Also, the Foreign Corrupt Practices Act and similar worldwide anti-bribery laws generally
8-K
EX-1.1
PNT
POINT Biopharma Global Inc.
14 Sep 22
POINT Biopharma Prices Public Offering of Common Stock
4:14pm
on Bribery of Foreign Public Officials in International Business Transactions, and the rules and regulations thereunder and any other similar foreign
S-3
EX-1.2
yhtmvvj
1 Jul 22
Shelf registration
4:13pm
424B3
1acrrn2eqz2oa8
31 Mar 22
Prospectus supplement
11:42am
POS AM
da80uyfv20j vrsc
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
424B3
0aolb60bs
5 Aug 21
Prospectus supplement
4:26pm
424B3
dqm 0zfs04c0v
9 Jun 21
Prospectus supplement
4:42pm
S-4/A
ih0 wvl3ptle3wh
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4
ndao47yg
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-2.1
fttvwg9mv
18 Mar 21
Financial Statements and Exhibits
9:08am
8-K
EX-1.1
kxrfqm6gfom4xk9px8
10 Jul 20
Therapeutics Acquisition Corp., Sponsored by RA Capital Management, L.P., Announces Pricing of Upsized $118 Million Initial Public Offering
5:17pm
S-1
EX-1.1
nk6b7peolkjyw3h4p
15 Jun 20
IPO registration
5:28pm
- Prev
- 1
- Next